Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer.

Rampias T, Karagiannis D, Avgeris M, Polyzos A, Kokkalis A, Kanaki Z, Kousidou E, Tzetis M, Kanavakis E, Stravodimos K, Manola KN, Pantelias GE, Scorilas A, Klinakis A.

EMBO Rep. 2019 Jan 21. pii: e46821. doi: 10.15252/embr.201846821. [Epub ahead of print]

PMID:
30665945
2.

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.

Guo G, Raje NS, Seifer C, Kloeber J, Isenhart R, Ha G, Yee AJ, O'Donnell EK, Tai YT, Richardson PG, Bianchi G, Laubach JP, Warren D, Gemme E, Voisine J, Frede J, Kokkalis A, Yun H, Dimitrova V, Vijaykumar T, Meyerson M, Munshi NC, Anderson KC, Knoechel B, Lohr JG.

Leukemia. 2018 Aug;32(8):1838-1841. doi: 10.1038/s41375-018-0115-z. Epub 2018 Mar 27. No abstract available.

PMID:
29749395
3.

The Histone Variant MacroH2A Blocks Cellular Reprogramming by Inhibiting Mesenchymal-to-Epithelial Transition.

Pliatska M, Kapasa M, Kokkalis A, Polyzos A, Thanos D.

Mol Cell Biol. 2018 Apr 30;38(10). pii: e00669-17. doi: 10.1128/MCB.00669-17. Print 2018 May 15.

4.

Short-term effects of hemodiafiltration versus conventional hemodialysis on erythrocyte performance.

Georgatzakou HT, Tzounakas VL, Kriebardis AG, Velentzas AD, Kokkalis AC, Antonelou MH, Papassideri IS.

Can J Physiol Pharmacol. 2018 Mar;96(3):249-257. doi: 10.1139/cjpp-2017-0285. Epub 2017 Aug 30.

PMID:
28854342
5.

Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.

Georgatzakou HT, Tzounakas VL, Kriebardis AG, Velentzas AD, Papageorgiou EG, Voulgaridou AI, Kokkalis AC, Antonelou MH, Papassideri IS.

Eur J Haematol. 2017 Jun;98(6):590-600. doi: 10.1111/ejh.12875. Epub 2017 Apr 12.

PMID:
28295628
6.

Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing.

Galanos P, Vougas K, Walter D, Polyzos A, Maya-Mendoza A, Haagensen EJ, Kokkalis A, Roumelioti FM, Gagos S, Tzetis M, Canovas B, Igea A, Ahuja AK, Zellweger R, Havaki S, Kanavakis E, Kletsas D, Roninson IB, Garbis SD, Lopes M, Nebreda A, Thanos D, Blow JJ, Townsend P, Sørensen CS, Bartek J, Gorgoulis VG.

Nat Cell Biol. 2016 Jul;18(7):777-89. doi: 10.1038/ncb3378. Epub 2016 Jun 20.

PMID:
27323328
7.

A method for generating highly multiplexed ChIP-seq libraries.

Ford E, Nikopoulou C, Kokkalis A, Thanos D.

BMC Res Notes. 2014 May 22;7:312. doi: 10.1186/1756-0500-7-312.

8.

Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: a 3-year follow-up pilot study.

Antonelou MH, Georgatzakou HT, Tzounakas VL, Velentzas AD, Kokkalis AC, Kriebardis AG, Papassideri IS.

J Proteomics. 2014 Apr 14;101:88-101. doi: 10.1016/j.jprot.2014.02.009. Epub 2014 Feb 15.

PMID:
24549005
9.

Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis.

Antonelou MH, Kriebardis AG, Velentzas AD, Kokkalis AC, Georgakopoulou SC, Papassideri IS.

J Proteomics. 2011 Oct 19;74(11):2441-52. doi: 10.1016/j.jprot.2011.04.009. Epub 2011 Apr 15.

PMID:
21515423

Supplemental Content

Loading ...
Support Center